Cabrera-Hernández A, Medina-Montalvo S, Mesa-Latorre JM, Vélez-Velázquez MD

Language: Spanish
References: 12
Page: 57-61
PDF size: 467.82 Kb.

ABSTRACT

We report a case involving a man who complained about progressively appearing multiple tumors, some of them painful, whose histological study was consistent with piloleiomyomas. The presence of multiple lesions can be found in the context of a familial syndrome, due to mutations in the fumarate hydratase gene that may occur in addition to kidney cancer and uterine fibroids. In our case, the finding of a complete deletion of this gene confirmed the diagnosis.

REFERENCES

1. Pastor MA, Carrasco L, Izquierdo MJ, Fariña MC, Martín L, Requena L. Piloleiomiomas faciales múltiples no familiares. Actas Dermosifiliogr. 2001; 92: 510-514.

2. Christenson LJ, Smith K, Arpey CJ. Treatment of multiple cutaneous leiomyomas with CO2 laser ablation. Dermatol Surg. 2000; 26: 319-322.

3. Onder M, Adisen E. A new indication of botulinum toxin: leiomyoma-related pain. J Am Acad Dermatol. 2009; 60: 325-328.

4. Badeloe S, van Geel M, van Steensel MA, Bastida J, Ferrando J, Steijlen PM et al. Diffuse and segmental variants of cutaneous leiomyomatosis: novel mutations in the fumarate hydratase gene and review of the literature. Exp Dermatol. 2006; 15: 735-741.

5. Badeloe S, Frank J. Clinical and molecular genetics aspects of hereditary multiple cutaneous leiomyomatosis. Eur J Dermatol. 2009; 19: 545-551.

6. Haugen RN, Tharp MD. The use of gabapentin for recurrent painful attacks with multiple piloleiomyomas. J Drugs Dermatol. 2008; 7: 401-402.

7. Lehtonen HJ. Hereditary leiomyomatosis and renal cell cancer: update on clinical and molecular characteristics. Fam Cancer. 2011; 10: 397-411.

8. Aoki KR. Review of a proposed mechanism for the antinociceptive action of botulinum toxin type A. Neurotoxicology. 2005; 26: 785-793.

9. Smit DL, Mensenkamp AR, Badeloe S, Breuning MH, Simon ME, van Spaendonck KY et al. Hereditary leiomyomatosis and renal cell cancer in families referred for fumarate hydratase germline mutation analysis. Clin Genet. 2011; 79: 49-59.

10. Wei MH, Toure O, Glenn GM, Pithukpakorn M, Neckers L, Stolle C et al. Novel mutations in FH and expansion of the spectrum of phenotypes expressed in families with hereditary leiomyomatosis and renal cell cancer. J Med Genet. 2006; 43: 18-27.

11. Kiuru M, Launonen V, Hietala M, Aittomäki K, Vierimaa O, Salovaara R et al. Familial cutaneous leiomyomatosis is a two-hit condition associated with renal cell cancer of characteristic histopathology. Am J Pathol. 2001; 159: 825-829.

12. Pithukpakorn M, Toro JR. Hereditary leiomyomatosis and renal cell cancer. Gene Reviews [Internet]. 2006 [acceso 3 de marzo de 2012]. Disponible en: http://www.ncbi.nlm.nih.gob/bookshelf. 2006.